Effectiveness of 2009 pandemic influenza A(H1N1) vaccines: A systematic review and meta-analysis

作者: Louise E. Lansbury , Sherie Smith , Walter Beyer , Emina Karamehic , Eva Pasic-Juhas

DOI: 10.1016/J.VACCINE.2017.02.059

关键词:

摘要: Background: The clinical effectiveness of monovalent influenza A(H1N1)pdm09 vaccines has not been comprehensively summarised. We undertook a systematic review and meta-analysis to assess vaccine (VE) for adjuvanted unadjuvanted vaccines. Methods: searched healthcare databases grey literature from 11 June 2009 12 November 2014. Two researchers independently assessed titles abstracts identify studies full review. Random effects meta-analyses estimated the pooled effect size vaccination compared placebo or no crude adjusted odds ratios (OR) prevent laboratory confirmed illness (LCI) related hospitalization. VE was calculated as (1-pooled OR) ∗ 100. Narrative synthesis undertaken where possible. Results: identified 9229 which 38 at moderate risk bias met protocol eligibility criteria; 23 were suitable meta-analysis. Pooled against LCI with both reached statistical significance (adjuvanted: = 80%; 95% confidence interval [CI] 59–90%; unadjuvanted: 66%; CI 47–78%); in planned secondary analyses, adults often failed reach point estimates lower than observed children. Overall hospitalization 61% (95% 14–82%); attained aged 18–64 years children Adjuvanted significantly more effective outcomes. Conclusions: preventing LCI. Overall, also influenza-related For outcomes adults.

参考文章(64)
SF Sutton, TS Carey, S West, KN Lohr, N McKoy, L Lux, V King, Systems to Rate the Strength of Scientific Evidence: Summary Agency for Healthcare Research and Quality (US). ,(2002)
J. Kevin Yin, Gulam Khandaker, Harunor Rashid, Leon Heron, Iman Ridda, Robert Booy, Immunogenicity and safety of pandemic influenza A (H1N1) 2009 vaccine: systematic review and meta‐analysis Influenza and Other Respiratory Viruses. ,vol. 5, pp. 299- 305 ,(2011) , 10.1111/J.1750-2659.2011.00229.X
Benedikt Fischer, Wayne Jones, Jürgen Rehm, High correlations between levels of consumption and mortality related to strong prescription opioid analgesics in British Columbia and Ontario, 2005-2009. Pharmacoepidemiology and Drug Safety. ,vol. 22, pp. 438- 442 ,(2013) , 10.1002/PDS.3404
P. G. Van Buynder, J. K. Dhaliwal, J. L. Van Buynder, C. Couturier, M. Minville-LeBlanc, R. Garceau, F.-W. Tremblay, Protective effect of single-dose adjuvanted pandemic influenza vaccine in children. Influenza and Other Respiratory Viruses. ,vol. 4, pp. 171- 178 ,(2010) , 10.1111/J.1750-2659.2010.00146.X
Yi Zhang, Holly Seale, Peng Yang, Chandini R. MacIntyre, Brett Blackwell, Song Tang, Quanyi Wang, Factors associated with the transmission of pandemic (H1N1) 2009 among hospital healthcare workers in Beijing, China Influenza and Other Respiratory Viruses. ,vol. 7, pp. 466- 471 ,(2013) , 10.1111/IRV.12025
J. Lim, B. Choi, J. Kim, J. Kim, C. Kim, J. Park, H. Yoon, S. Hong, J. Seo, M. Ki, Evaluation and sensitivity analysis of the effectiveness of unadjuvanted A(H1N1)pdm09 vaccine in hospital workers using multi-center cohort study in Korea. Vaccine. ,vol. 31, pp. 2381- 2386 ,(2013) , 10.1016/J.VACCINE.2013.02.066
Maria D Van Kerkhove, Siddhivinayak Hirve, Artemis Koukounari, Anthony W Mounts, H1N1pdm Serology Working Group, None, Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries Influenza and Other Respiratory Viruses. ,vol. 7, pp. 872- 886 ,(2013) , 10.1111/IRV.12074
Thomas Seyler, Antonino Bella, Simona Puzelli, Isabella Donatelli, Caterina Rizzo, screening method working group, Estimating pandemic vaccine effectiveness in two Italian regions using the screening method, 2009-2010. Vaccine. ,vol. 30, pp. 109- 111 ,(2012) , 10.1016/J.VACCINE.2011.11.013